Transient receptor potential canonical (TRPC) channels in diabetes and associated complications

Yi Wu1, Shengming Chen2, Xiaolu Xia2

  • 1Collaborative Innovation Center for Biomedicine, Shanghai University of Medicine and Health Sciences, Shanghai, China.

Insights

Transient Receptor Potential Canonical (TRPC) channels are crucial for pancreatic beta cell function and insulin secretion. This review explores their roles in type 2 diabetes mellitus and its complications, highlighting therapeutic potential.

Area of Science:

  • Molecular Biology
  • Endocrinology
  • Physiology

Background:

  • Transient Receptor Potential Canonical (TRPC) channels are expressed in various tissues, including pancreatic beta cells.
  • TRPC channels are increasingly recognized for their roles in regulating insulin secretion.
  • Dysregulation of TRPC channels is linked to type 2 diabetes mellitus (T2DM) and its complications.

Purpose of the Study:

  • To provide a comprehensive review of TRPC channel distribution and function in the context of diabetes.
  • To elucidate the specific roles of TRPC subtypes in insulin secretion, insulin resistance, and diabetic complications.
  • To address controversies regarding TRPC expression patterns and physiological significance.

Main Methods:

  • Literature review of current research on TRPC channels.
  • Analysis of studies investigating TRPC channel function in pancreatic beta cells.
  • Examination of evidence linking TRPC channels to T2DM pathogenesis and complications.

Main Results:

  • TRPC channels are vital for normal insulin secretion.
  • Altered TRPC channel activity contributes to insulin resistance and T2DM development.
  • Specific TRPC subtypes show differential involvement in diabetic complications.

Conclusions:

  • TRPC channels represent promising therapeutic targets for T2DM and its complications.
  • Further research is needed to clarify the precise roles and regulation of individual TRPC subtypes in diabetes.
  • Understanding TRPC channel function is critical for developing novel diabetes treatments.

Related Concept Videos

Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Diabetic Neuropathy01:22

Diabetic Neuropathy

DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...
Complications of Diabetes Mellitus01:22

Complications of Diabetes Mellitus

Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia due to insulin deficiency, resistance, or both. Prolonged hyperglycemia disrupts metabolic homeostasis and leads to acute and chronic complications.Acute ComplicationsAcute complications result from sudden metabolic imbalance.Diabetic ketoacidosis (DKA) mainly appears in type 1 diabetes but may also develop in type 2 diabetes, particularly under extreme stress. It arises from severe insulin deficiency,...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...